Member Description Overlay
SVB Leerink People

At SVB Leerink, we share a common desire to achieve the highest level of success for our clients. We pride ourselves on being the most focused and passionate healthcare investment banking professionals. We leverage our combined knowledge and experience to empower our clients to make well-informed strategic decisions that create opportunity and shareholder value while paving the way for the innovations that improve human health.

Jeffrey A. Leerink

Chief Executive Officer

close

Jeffrey A. Leerink

Chief Executive Officer

Jeffrey A. Leerink is the Chief Executive Officer of SVB Leerink. Mr. Leerink is charged with defining, leading and executing the firm’s overarching business strategy and driving clarity, alignment and profitability across the entire business. Under Mr. Leerink’s leadership, the firm has grown to become a leading healthcare investment bank and company building partner.

Mr. Leerink founded Leerink Partners in 1995 and in 2019 merged the firm with SVB Financial Group, parent company to Silicon Valley Bank, to become SVB’s investment banking platform. The firm is focused on providing differentiated healthcare knowledge and equity capital markets, equity research and mergers and acquisitions expertise to help its clients define and achieve their strategic and capital markets objectives.

In 2008, Mr. Leerink co-founded and was a member of the Board of Directors of Humedica, Inc., a clinical intelligence company that was incubated at Leerink Partners. In 2013 the company was acquired by Optum, a subsidiary of UnitedHealth Group.

Mr. Leerink currently serves on the Board of Fog Pharmaceuticals and was the former Chairman of the Board of Big Brother Big Sisters of Massachusetts Bay.  Mr. Leerink is a member of the Harvard Medical School Board of Fellows and is the Vice Chair of the New England Chapter of CEO’s Against Cancer.

Mr. Leerink holds a B.A. in Economics from Union College.

Jim Boylan

President, Head of Investment Banking

close

Jim Boylan

President, Head of Investment Banking

James (Jim) Boylan is the President & Head of Investment Banking at SVB Leerink. Mr. Boylan has 25 years of experience in healthcare investment banking.

Prior to joining the firm in 2009, Mr. Boylan was a Managing Director at Merrill Lynch & Co. where he was in the Healthcare group from 2005-2009 and in the Mergers & Acquisitions department from 1997-2004. Mr. Boylan’s deal experience includes more than 100 transactions where he has helped his clients complete the full cadre of M&A and financing transactions across the pharma / biotech, medical devices, healthcare services and diagnostics & life science tools sectors.

Mr. Boylan earned his MBA from Columbia University and a B.S. from Lehigh University.

John L. Sullivan, CFA

Senior Managing Director, Director of Equity Research & Healthcare Investment Strategist

close

John L. Sullivan, CFA

Senior Managing Director, Director of Equity Research & Healthcare Investment Strategist

John L. Sullivan is the Director of Equity Research & Healthcare Investment Strategist at SVB Leerink.

Prior to joining the firm in 2004, Mr. Sullivan was a Vice President, Senior Equity Research Analyst at Stephens Inc. where his primary focus was on companies possessing enabling technologies for health care-related products for research and drug discovery.

As a sector analyst, Mr. Sullivan ranked #3 in The Wall Street Journal’s 2008 “Best on the Street” analysts’ survey. As a stock picker in 2007, he earned a #2 ranking among the life sciences tools and services analysts ranked by StarMine in Forbes.com and a #3 ranking among the same group for accuracy of his earnings estimates.

Mr. Sullivan earned his undergraduate degree in Finance from Boston University, a graduate degree in Finance from Northwestern University’s Kellogg School of Management and a graduate degree in Government from Harvard University. Mr. Sullivan is a CFA charterholder.

Joseph Gentile

Chief Administrative Officer

close

Joseph Gentile

Chief Administrative Officer

Joseph Gentile is the Chief Administrative Officer at SVB Leerink.

Prior to joining the firm in 2007, Mr. Gentile served as the CFO for Lehman Brothers’ Global Investment Bank where he directed the accounting and financial needs within the Fixed Income division.  Prior to that, he served as CFO of the Global Corporate and Investment Bank at Bank of America, where he led the Capital Markets Division.  In addition he was the CFO for the Private Bank. Previously, Mr. Gentile spent more than 10 years with J.P. Morgan in various financial management positions, including Global Head of Financial Risk Management. He started his career at Arthur Andersen.

Mr. Gentile earned his B.S. in Accounting and an MBA in Finance from St. John’s University.

Dan Dubin, M.D.

Vice Chairman, Head of Biopharma Investment Banking

close

Dan Dubin, M.D.

Vice Chairman, Head of Biopharma Investment Banking

Dan Dubin, M.D. is the Vice Chairman and Head of Biopharma Investment Banking at SVB Leerink and sits on the firm’s executive committee.

For over 20 years, Dr. Dubin has advised life sciences companies and investors and has executed numerous financing, partnership, and M&A transactions for clients. Prior to joining the firm in 1999, Dr. Dubin co-founded MEDACorp, a provider of insights on the commercial potential of biotherapeutics and medical devices to healthcare companies and investors. Preceding the founding of MEDACorp, he was an Instructor in Dermatology at Harvard Medical School and held a staff appointment at the Brigham and Women’s Hospital where he was the Ambulatory Medical Director of Clinical Dermatology and a member of the Clinical Executive Committee.

Dr. Dubin serves as a director of Olivo Labs and has served as a director of Leerink Partners and Living Proof. Additionally he has served as Chairman of MetaWorks, which was sold to UBC in 2005. He also served as a member of the Science and Strategy Advisory Committee to GSK/Stiefel and an advisor to SKS Ocular.

Dr. Dubin is a graduate of Dartmouth College and Harvard Medical School and completed both an internship in Medicine and a residency in Dermatology at the Massachusetts General Hospital. He has published over 30 manuscripts in peer reviewed publications and performed a NIH training fellowship at the Harvard Skin Disease Research Center.

Steven Heineman

Senior Managing Director, General Counsel

close

Steven Heineman

Senior Managing Director, General Counsel

Steven Heineman is the General Counsel and Senior Managing Director of the Compliance and Legal Department at SVB Leerink.

Prior to joining the firm in 2018, Mr. Heineman was the General Counsel at Convergex Group, LLC, a global brokerage and trading-related services provider. Before that, he was the General Counsel-Americas at Société Générale. Prior to being named General Counsel at SocGen, Mr. Heineman was the Director of Litigation & Regulatory Affairs.  Previously, Mr. Heineman practiced law at Debevoise & Plimpton LLP, where he specialized in complex commercial litigation, white collar criminal defense and regulatory enforcement matters.  He also served as a federal prosecutor in the Criminal Division of the United States Attorney’s Office for the Southern District of New York.

Mr. Heineman earned his B.A. degree in Political Science from Hobart College and his J.D. from New York University School of Law.

Robert Leerink

Senior Managing Director, Head of Institutional Equities

close

Robert Leerink

Senior Managing Director, Head of Institutional Equities

Robert Leerink is a Senior Managing Director and Head of Institutional Equities at SVB Leerink.

Mr. Leerink has been with SVB Leerink since its inception in 1995. Prior to joining Institutional Sales team in 2000, Mr. Leerink led the Private Client Services group at the firm. Prior to SVB Leerink, Mr. Leerink worked in the Private Client Services division of Fechtor Detwiler.

Mr. Leerink holds a bachelor’s degree from Babson College.

Check the background of this investment professional on FINRA’s BrokerCheck.

Maura Polak

Managing Director, Human Resources

close

Maura Polak

Managing Director, Human Resources

Maura Polak is the Head of Human Resources at SVB Leerink. Ms. Polak has over 15 years of experience in Human Resources and leads all of SVB Leerink’s recruiting, employee relations, compensation and benefits initiatives.

Prior to joining the firm in 2004, Ms. Polak worked at Peer Review Analysis, a Division of Fortis, Inc., as a Human Resources Representative where she managed through a series of mergers, acquisitions and a divestiture.

Ms. Polak earned her B.A. in both Psychology and Spanish from Providence College.